MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 154 filers reported holding MERSANA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $52,904 | -60.7% | 41,657 | +1.9% | 0.00% | – |
| Q2 2023 | $134,449 | -8.1% | 40,866 | +14.8% | 0.00% | – |
| Q1 2023 | $146,304 | -29.9% | 35,597 | 0.0% | 0.00% | – |
| Q4 2022 | $208,598 | -12.6% | 35,597 | +0.8% | 0.00% | – |
| Q3 2022 | $238,736 | +42.2% | 35,316 | -2.8% | 0.00% | – |
| Q2 2022 | $167,886 | +34.2% | 36,339 | +15.9% | 0.00% | – |
| Q1 2022 | $125,126 | -47.9% | 31,360 | -18.7% | 0.00% | – |
| Q4 2021 | $240,000 | -33.1% | 38,574 | +1.4% | 0.00% | – |
| Q3 2021 | $359,000 | -33.6% | 38,053 | -4.4% | 0.00% | – |
| Q2 2021 | $541,000 | +9.5% | 39,806 | +30.3% | 0.00% | – |
| Q1 2021 | $494,000 | -42.2% | 30,541 | -5.0% | 0.00% | -100.0% |
| Q4 2020 | $855,000 | +49.7% | 32,148 | +4.9% | 0.00% | 0.0% |
| Q3 2020 | $571,000 | -6.2% | 30,655 | +12.2% | 0.00% | 0.0% |
| Q2 2020 | $609,000 | +335.0% | 27,315 | +14.0% | 0.00% | – |
| Q1 2020 | $140,000 | +109.0% | 23,959 | +105.4% | 0.00% | – |
| Q4 2019 | $67,000 | -40.7% | 11,666 | -58.0% | 0.00% | – |
| Q2 2019 | $113,000 | -41.8% | 27,797 | +156.1% | 0.00% | – |
| Q2 2018 | $194,000 | +30.2% | 10,855 | +14.3% | 0.00% | – |
| Q1 2018 | $149,000 | +496.0% | 9,496 | +505.6% | 0.00% | – |
| Q4 2017 | $25,000 | +177.8% | 1,568 | +207.5% | 0.00% | – |
| Q3 2017 | $9,000 | – | 510 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 1,191,271 | $6,980,848 | 6.79% |
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $50,769 | 5.67% |
| ACUTA CAPITAL PARTNERS, LLC | 950,000 | $5,567,000 | 3.43% |
| Sarissa Capital Management LP | 3,997,010 | $23,422,479 | 2.79% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $5,299,010 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,140,182 | $6,681,467 | 1.91% |
| Orbimed Advisors | 9,011,437 | $52,807,021 | 1.01% |
| Opaleye Management Inc. | 460,000 | $2,695,600 | 0.94% |
| Artal Group S.A. | 2,200,000 | $12,892 | 0.72% |
| DAFNA Capital Management LLC | 413,463 | $2,422,893 | 0.68% |